Education
About Us
Working with TipRanks
Follow Us
Earnings Calendar - Nov 13, 2024
Showing earnings announcements on Nov 13, 2024
Name | Company | Market Cap | EPS (Forecast) | EPS (Actual) | Revenue (Forecast) | Revenue (Actual) | Time | Analyst Consensus | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
 | Cisco Systems | $241.36B | $0.87 | $13.78B | xxxxxxxxxxxxx | |||||
 | BioNano Genomics | $10.03M | -$11.85 | $7.76M | xxxxxxxxxxxxx | |||||
 | Tencent Holdings | $602.73B | $0.80 | $23.61B | xxxxxxxxxxxxx | |||||
 | Nu Holdings | $50.68B | $0.11 | $2.61B | xxxxxxxxxxxxx | |||||
 | Canoo | $1.88M | -$15.31 | $1.80M | xxxxxxxxxxxxx | |||||
 | Vaxart | $105.32M | -$0.10 | $1.93M | xxxxxxxxxxxxx | |||||
 | CyberArk Software | $16.31B | $0.46 | $234.10M | xxxxxxxxxxxxx | |||||
 | Paysafe | $868.98M | $0.61 | $423.15M | xxxxxxxxxxxxx | |||||
 | KULR Technology Group | $270.38M | -$0.02 | $2.40M | xxxxxxxxxxxxx | |||||
 | Jaguar Animal Health | $7.82M | -$2.37 | $3.90M | xxxxxxxxxxxxx | |||||
 | Stratasys | $696.29M | -$0.04 | $139.49M | xxxxxxxxxxxxx | |||||
 | Talphera | $9.37M | -$0.19 | $0.00 | xxxxxxxxxxxxx | |||||
 | Ceragon Networks | $208.67M | $0.09 | $101.51M | xxxxxxxxxxxxx | |||||
 | Ecopetrol SA | $19.78B | $0.44 | $8.01B | xxxxxxxxxxxxx | |||||
 | Tower | $4.09B | $0.54 | $370.30M | xxxxxxxxxxxxx | |||||
 | Spruce Power Holding | $45.39M | -$0.10 | $22.80M | xxxxxxxxxxxxx | |||||
 | Gilat | $395.70M | $0.07 | $76.77M | xxxxxxxxxxxxx | |||||
 | Durect | $25.40M | -$0.16 | $2.00M | xxxxxxxxxxxxx | |||||
 | Sonos | $1.39B | -$0.40 | $247.93M | xxxxxxxxxxxxx | |||||
 | Pagseguro Digital | $2.41B | $0.29 | $790.94M | xxxxxxxxxxxxx | |||||
 | Innoviz Technologies | $135.89M | -$0.13 | $4.45M | xxxxxxxxxxxxx | |||||
 | Aytu BioScience | $7.77M | -$0.34 | $13.77M | xxxxxxxxxxxxx | |||||
 | Gladstone Capital | $597.55M | $0.53 | $23.92M | xxxxxxxxxxxxx | |||||
 | ATAI Life Sciences | $275.47M | -$0.16 | $0.00 | xxxxxxxxxxxxx | |||||
 | Grace Therapeutics | $32.10M | -$0.37 | $0.00 | xxxxxxxxxxxxx | |||||
 | Quantum | $59.68M | -$1.10 | $72.50M | xxxxxxxxxxxxx | |||||
 | Astria Therapeutics | $365.13M | -$0.42 | $0.00 | xxxxxxxxxxxxx | |||||
 | Seres Therapeutics | $125.08M | -$0.08 | $31.00M | xxxxxxxxxxxxx | |||||
 | Boxlight | $3.02M | -$0.82 | $41.06M | xxxxxxxxxxxxx | |||||
 | Clene | $37.80M | -$1.33 | $107.00K | xxxxxxxxxxxxx | |||||
 | Cocrystal Pharma | $16.89M | -$0.57 | $0.00 | xxxxxxxxxxxxx | |||||
 | Structure Therapeutics, Inc. Sponsored ADR | $1.18B | -$0.18 | $0.00 | xxxxxxxxxxxxx | |||||
 | X4 Pharmaceuticals | $54.32M | -$0.17 | $1.69M | xxxxxxxxxxxxx | |||||
 | Taysha Gene Therapies | $354.65M | -$0.09 | $1.74M | xxxxxxxxxxxxx | |||||
 | SELLAS Life Sciences Group | $92.73M | -$0.13 | $0.00 | xxxxxxxxxxxxx | |||||
 | Viracta Therapeutics | $1.31M | -$0.27 | $0.00 | xxxxxxxxxxxxx | |||||
 | Capricor Therapeutics | $572.01M | -$0.36 | $4.28M | xxxxxxxxxxxxx | |||||
 | Helmerich & Payne | $2.51B | $0.80 | $695.99M | xxxxxxxxxxxxx | |||||
 | Electrocore | $87.73M | -$0.33 | $6.71M | xxxxxxxxxxxxx | |||||
 | Leap Therapeutics | $15.94M | -$0.49 | $0.00 | xxxxxxxxxxxxx | |||||
 | Metagenomi, Inc. | $75.60M | -$0.78 | $6.76M | xxxxxxxxxxxxx | |||||
 | Adaptimmune Therapeutics | $114.38M | >-$0.01 | $18.96M | xxxxxxxxxxxxx | |||||
 | Ontrak | $6.03M | -$1.56 | $2.60M | xxxxxxxxxxxxx | |||||
 | Gyre Therapeutics | $974.08M | ― | ― | xxxxxxxxxxxxx | |||||
 | Vivani Medical | $62.20M | -$0.10 | $0.00 | xxxxxxxxxxxxx | |||||
 | Blum Holdings | $6.43M | ― | ― | xxxxxxxxxxxxx | |||||
 | Equillium | $26.14M | $0.02 | $11.55M | xxxxxxxxxxxxx | |||||
 | Digital Ally | $6.30M | ― | ― | ― | ― | ― | xxxxxxxxxxxxx | ||
 | Omeros | $428.25M | -$0.70 | $0.00 | xxxxxxxxxxxxx | |||||
 | Sutro Biopharma | $105.55M | -$0.73 | $15.29M | xxxxxxxxxxxxx | |||||
 | Smith Micro Software | $19.07M | -$0.31 | $4.71M | xxxxxxxxxxxxx | |||||
 | Kyverna Therapeutics, Inc. | $110.52M | -$0.81 | $0.00 | xxxxxxxxxxxxx | |||||
 | Kulicke & Soffa | $1.90B | $0.35 | $180.03M | xxxxxxxxxxxxx | |||||
 | AFC Gamma | $183.52M | $0.34 | $12.41M | xxxxxxxxxxxxx | |||||
 | Oruka Therapeutics | $414.09M | -$0.40 | $0.00 | xxxxxxxxxxxxx | |||||
 | Tetra Tech | $7.86B | $0.37 | $1.13B | xxxxxxxxxxxxx | |||||
 | Tenax Therapeutics | $23.44M | -$1.37 | $0.00 | xxxxxxxxxxxxx | |||||
 | Liquidia Technologies | $1.18B | -$0.37 | $4.16M | xxxxxxxxxxxxx | |||||
 | Mersana Therapeutics | $60.17M | -$0.17 | $7.53M | xxxxxxxxxxxxx | |||||
 | Xos | $27.54M | -$1.35 | $22.80M | xxxxxxxxxxxxx | |||||
 | Quince Therapeutics | $63.36M | -$0.17 | $0.00 | xxxxxxxxxxxxx | |||||
 | Aethlon Medical | $6.51M | -$0.20 | $0.00 | xxxxxxxxxxxxx | |||||
 | Companhia Energetica Minas Gerais | $6.19B | $0.13 | $1.61B | xxxxxxxxxxxxx | |||||
 | Passage Bio | $25.68M | -$0.23 | $1.67M | xxxxxxxxxxxxx | |||||
 | Adial Pharmaceuticals | $4.17M | -$0.40 | $0.00 | xxxxxxxxxxxxx | |||||
 | Ellington Residential Mortgage | $178.56M | $0.31 | $5.56M | xxxxxxxxxxxxx | |||||
 | Arcos Dorados Holdings | $1.64B | $0.16 | $1.13B | xxxxxxxxxxxxx | |||||
 | DLocal | $2.44B | $0.11 | $181.47M | ― | xxxxxxxxxxxxx | ||||
 | Fulcrum Therapeutics | $159.78M | -$0.40 | $0.00 | xxxxxxxxxxxxx | |||||
 | OptimizeRx | $76.26M | $0.06 | $24.99M | xxxxxxxxxxxxx | |||||
 | Diamedica Therapeutics | $239.89M | -$0.15 | $0.00 | xxxxxxxxxxxxx | |||||
 | scPharmaceuticals | $154.12M | -$0.30 | $10.81M | xxxxxxxxxxxxx | |||||
 | Banco do Brasil SA | $27.34B | $0.30 | $6.83B | xxxxxxxxxxxxx | |||||
 | Intellicheck Mobilisia | $46.24M | -$0.01 | $4.78M | xxxxxxxxxxxxx | |||||
 | Fusion Fuel Green | $8.34M | -$0.25 | ― | $4.55M | ― | ― | xxxxxxxxxxxxx | ||
 | Dada Nexus | $488.54M | -$0.07 | $327.15M | xxxxxxxxxxxxx | |||||
 | Gryphon Digital Mining | $14.63M | -$0.16 | $3.90M | xxxxxxxxxxxxx | |||||
 | SinglePoint | $87.47K | ― | ― | ― | ― | ― | xxxxxxxxxxxxx | ||
 | Venus Concept | $1.81M | -$12.48 | $17.27M | xxxxxxxxxxxxx | |||||
 | Predictive Oncology | $7.71M | -$0.32 | $500.00K | xxxxxxxxxxxxx | |||||
 | Safe Bulkers | $390.66M | $0.17 | $71.52M | xxxxxxxxxxxxx | |||||
 | iCAD | $58.65M | -$0.08 | $4.51M | xxxxxxxxxxxxx | |||||
 | Broadwind Energy | $33.70M | -$0.04 | $36.70M | xxxxxxxxxxxxx | |||||
 | GOL Linhas Aereas Inteligentes SA | $99.03M | -$0.85 | $855.17M | xxxxxxxxxxxxx | |||||
 | Meiragtx Holdings | $476.74M | -$0.56 | $1.20M | xxxxxxxxxxxxx | |||||
 | Unicycive Therapeutics | $60.28M | -$0.15 | $0.00 | xxxxxxxxxxxxx | |||||
 | Lucid Diagnostics | $102.04M | -$0.21 | $1.14M | xxxxxxxxxxxxx | |||||
 | Mural Oncology Plc | $64.83M | -$1.97 | $0.00 | xxxxxxxxxxxxx | |||||
 | ESS Tech | $37.07M | -$1.68 | $5.25M | xxxxxxxxxxxxx | |||||
 | Digi International | $1.05B | $0.47 | $104.16M | xxxxxxxxxxxxx | |||||
 | Porsche Automobil Holding | $13.00B | ― | ― | ― | xxxxxxxxxxxxx | ||||
 | SeaStar Medical Holding | $16.83M | -$1.13 | $75.00K | xxxxxxxxxxxxx | |||||
 | Inspire Veterinary Partners, Inc. Class A | $2.99M | ― | ― | xxxxxxxxxxxxx | |||||
 | Stronghold Digital Mining | $47.92M | -$0.62 | $16.15M | ― | xxxxxxxxxxxxx | ||||
 | BurgerFi International | $27.00 | -$0.16 | ― | $39.54M | ― | ― | xxxxxxxxxxxxx | ||
 | ARS Pharmaceuticals | $1.12B | -$0.14 | $575.00K | xxxxxxxxxxxxx | |||||
 | Catheter Precision | $3.05M | -$2.20 | $100.00K | xxxxxxxxxxxxx | |||||
 | Instil Bio | $113.22M | -$2.11 | $1.90M | xxxxxxxxxxxxx | |||||
 | 4D Molecular Therapeutics | $190.30M | -$0.68 | $1.62M | xxxxxxxxxxxxx | |||||
 | Harrow Health | $815.58M | -$0.05 | $52.80M | xxxxxxxxxxxxx |
Rows:
Earnings News
FAQ
When is Earnings Season?
The earnings season usually begins one to two weeks after the end of the last month of each quarter (December, March, June, and September).
How do earnings affect stock prices?
A company's earnings report reveals its profitability and financial stability. If a company’s earnings are reported above expectations, its stock price tends to rise. However, depending on forward guidance and macroeconomic factors, a stock price is still susceptible to volatility.
Is it better to buy a stock before or after earnings?
Stock prices tend to be more volatile before and after a company reports its earnings. Investors should develop an investment thesis using Earnings Reports Insights and other datasets before making any investment decisions.